MedPath
HSA Approval

SUNVASC 5 TABLET 5MG

SIN14005P

SUNVASC 5 TABLET 5MG

SUNVASC 5 TABLET 5MG

August 31, 2011

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Sunward Pharmaeutical Sdn.Bhd

Active Ingredients

Amlodipine Besylate 6.934mg eqv Amlodipine

5 mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUNVASC 5 TABLET 5MG - HSA Approval | MedPath